Function, activity and participation limitations in patients with post-COVID condition: a multicenter analysis from two prospective German cohorts

Based on the WHO definition of post-COVID condition (PCC), its symptoms can cause limitations in activity and participation of daily living. However, studies investigating this association are rare. This study aims to examine relevant activity and participation impairments in PCC patients as well as determinants for said impairments using established cohort studies in Germany. Data from patients included in the two inpatient cohorts of the National Pandemic Cohort Network (NAPKON) were used. Within the two cohorts, patients from 32 hospitals were included and evaluated at 3 and 12 months follow up (3MFU, 12MFU) after baseline examination. The previously developed PCC score (PCCS) was used for measuring PCC severity. To assess activity and participation impairment, the PROMIS-29 domain ‘ability to participate in social roles and activities’ was used. Defined other deficits in different areas of life were assessed by defined PROMIS domains. Overall, 655 patients with available information on PCCS and PROMIS at 3MFU and 374 patients at 12MFU were included between 2020 and 2023 , of whom 76% and 70% had at least a mild PCC, respectively. At 3MFU, 43% of patients with at least mild PCC had evidence for activity and participation impairment. 17% of these still had at least mild PCC and activity and participation impairments at 12MFU. They further had significantly lower quality of life, higher PCCS and more comorbidities than patients without PCC at 3 and 12 MFU (3MFU/12MFU: p<.001/p<.001, p<.001/p<.001, p=.004/p=.025, respectively). ​Even when multiple symptoms are present, PCC is not always associated with limitations in activity and participation. As such restrictions are important for rehabilitation planning, further studies should specifically address the risk of PCC patients to develop an impairment in activity and participation. Trail registration: The NAPKON SUEP is registered at ClinicalTrials.gov (Identifier: NCT04768998). The NAPKON HAP is registered at ClinicalTrials.gov (Identifier: NCT04747366).

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-21
DOI
https://doi.org/10.1038/s41598-026-81336-w
Primary Topic
Long-Term Effects of COVID-19
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Function, activity and participation limitations in patients with post-COVID condition: a multicenter analysis from two prospective German cohorts

Christoph Römmele, Anke Steinmetz, Thomas Bahmer, Christian H. Neumann et al.
Scientific Reports
Long-Term Effects of COVID-19
article

Function, activity and participation limitations in patients with post-COVID condition: a multicenter analysis from two prospective German cohorts

Christoph Römmele, Anke Steinmetz, Thomas Bahmer, Christian H. Neumann, Carolin Nürnberger, Margarete Scherer, Frank Hanses, Peter Ulrich Heuschmann, Tanja Kraus, Sandra Frank, Philipp Alexander Reuken, Edgar Dahl, Jürgen Deckert, Michael Krawczak, Jens‐Peter Reese, Philipp A. Koehler, Beate Balzuweit, Katharina S. Appel, Robin Kobbe, Thomas Illig, Hiwa Dashti, Jana Butzmann, Isabel Bröhl, K Fiedler, Martin Witzenrath, Shimita Raquib, Sina M. Pütz, Björn-Erik Ole Jensen, Christina Lemhöfer, Jörg J. Vehreschild, M. Christina Polidori
article en

Abstract

Based on the WHO definition of post-COVID condition (PCC), its symptoms can cause limitations in activity and participation of daily living. However, studies investigating this association are rare. This study aims to examine relevant activity and participation impairments in PCC patients as well as determinants for said impairments using established cohort studies in Germany. Data from patients included in the two inpatient cohorts of the National Pandemic Cohort Network (NAPKON) were used. Within the two cohorts, patients from 32 hospitals were included and evaluated at 3 and 12 months follow up (3MFU, 12MFU) after baseline examination. The previously developed PCC score (PCCS) was used for measuring PCC severity. To assess activity and participation impairment, the PROMIS-29 domain ‘ability to participate in social roles and activities’ was used. Defined other deficits in different areas of life were assessed by defined PROMIS domains. Overall, 655 patients with available information on PCCS and PROMIS at 3MFU and 374 patients at 12MFU were included between 2020 and 2023 , of whom 76% and 70% had at least a mild PCC, respectively. At 3MFU, 43% of patients with at least mild PCC had evidence for activity and participation impairment. 17% of these still had at least mild PCC and activity and participation impairments at 12MFU. They further had significantly lower quality of life, higher PCCS and more comorbidities than patients without PCC at 3 and 12 MFU (3MFU/12MFU: p<.001/p<.001, p<.001/p<.001, p=.004/p=.025, respectively). ​Even when multiple symptoms are present, PCC is not always associated with limitations in activity and participation. As such restrictions are important for rehabilitation planning, further studies should specifically address the risk of PCC patients to develop an impairment in activity and participation. Trail registration: The NAPKON SUEP is registered at ClinicalTrials.gov (Identifier: NCT04768998). The NAPKON HAP is registered at ClinicalTrials.gov (Identifier: NCT04747366).

Scientific ReportsVol. 16(1)
Goethe University Frankfurt (DE), University of Cologne (DE), University of Würzburg (DE), Universitätsmedizin Greifswald (DE), Frankfurt Institute for Advanced Studies (DE), University Hospital Augsburg (DE), LMU Klinikum (DE), University Hospital Regensburg (DE), Christian-Albrechts-Universität zu Kiel (DE), Medizinische Hochschule Hannover (DE), Humboldt-Universität zu Berlin (DE), Düsseldorf University Hospital (DE), Universitätsklinikum Tübingen (DE), University Medical Center Hamburg-Eppendorf (DE), University Hospital Schleswig-Holstein (DE), Eberswalde University for Sustainable Development (DE), Universitätsklinikum Aachen (DE), Universitätsklinikum Würzburg (DE), German Center for Lung Research (DE), Jena University Hospital (DE), Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (DE), University Hospital Magdeburg (DE), University Hospital Cologne (DE), Heinrich Heine University Düsseldorf (DE), Friedrich Schiller University Jena (DE), Ludwig-Maximilians-Universität München (DE), RWTH Aachen University (DE), Bernhard Nocht Institute for Tropical Medicine (DE), Otto-von-Guericke-Universität Magdeburg (DE)
Long-Term Effects of COVID-19
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon